Related Experiment Video
Updated: Jun 4, 2026

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity
Li-Jun Ma1, Bridgette A Corsa, Jun Zhou
1Department of Pathology, Vanderbilt Univ. Medical Center, Nashville, TN 37232-2561, USA. Lijun.ma@vanderbilt.edu
Abstract:
The mechanisms for increased risk of chronic kidney disease (CKD) in obesity remain unclear. The renin-angiotensin system is implicated in the pathogenesis of both adiposity and CKD. We investigated whether the angiotensin type 1 (AT(1)) receptor, composed of dominant AT(1a) and less expressed AT(1b) in wild-type (WT) mice, modulates development and progression of kidney injury in a high-fat diet (HFD)-induced obesity model. WT mice had increased body weight, body fat, and insulin levels and decreased adiponectin levels after 24 wk of a high-fat diet. Identically fed AT(1a) knockout (AT1aKO) mice gained weight similarly to WT mice, but had lower body fat and higher plasma cholesterol. Both obese AT1aKO and obese WT mice had increased visceral fat and kidney macrophage infiltration, with more proinflammatory M1 macrophage markers as well as increased mesangial expansion and tubular vacuolization, compared with lean mice. These abnormalities were heightened in the obese AT1aKO mice, with downregulated M2 macrophage markers and increased macrophage AT(1b) receptor. Treatment with an AT(1) receptor blocker, which affects both AT(1a) and AT(1b), abolished renal macrophage infiltration with inhibition of renal M1 and upregulation of M2 macrophage markers in obese WT mice. Our data suggest obesity accelerates kidney injury, linked to augmented inflammation in adipose and kidney tissues and a proinflammatory shift in macrophage and M1/M2 balance.
Insights
Obesity accelerates kidney injury by increasing inflammation and shifting macrophage balance towards a proinflammatory state. Blocking the angiotensin type 1 receptor reduces these harmful effects in obese mice.
Area of Science:
- Nephrology
- Metabolic Diseases
- Immunology
Background:
- Obesity is a risk factor for chronic kidney disease (CKD), but mechanisms are unclear.
- The renin-angiotensin system plays a role in both obesity and CKD.
- Angiotensin type 1 (AT(1)) receptor subtypes (AT(1a) and AT(1b)) are key components.
Purpose of the Study:
- Investigate the role of the AT(1a) receptor in high-fat diet (HFD)-induced obesity and kidney injury.
- Determine the impact of AT(1) receptor blockade on obesity-related renal inflammation and macrophage polarization.
Main Methods:
- Used wild-type (WT) and AT(1a) knockout (AT1aKO) mice fed a HFD for 24 weeks.
- Assessed metabolic parameters, body composition, and kidney histology.
- Analyzed kidney and adipose tissue macrophage infiltration and M1/M2 polarization markers.
- Administered an AT(1) receptor blocker to obese WT mice.
Main Results:
- HFD induced obesity, insulin resistance, and kidney injury (mesangial expansion, tubular vacuolization) in WT mice.
- AT1aKO mice had altered body fat and cholesterol but similar weight gain and kidney injury compared to obese WT mice.
- Both obese groups showed increased kidney macrophage infiltration and M1 markers; AT1aKO mice had heightened abnormalities and increased AT(1b) expression.
- AT(1) receptor blockade reduced renal macrophage infiltration, M1 markers, and promoted M2 markers in obese WT mice.
Conclusions:
- Obesity exacerbates kidney injury through increased inflammation in adipose and kidney tissues.
- A proinflammatory shift in macrophage M1/M2 balance contributes to obesity-related kidney damage.
- Targeting the AT(1) receptor may mitigate obesity-induced kidney injury by modulating inflammation.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension II: Pathophysiology
Hormonal Regulation

